Growth Metrics

Standard Biotools (LAB) Net Margin (2010 - 2026)

Standard Biotools (LAB) reported Net Margin of 670.07% for Q1 2026, up 68324.0% year-over-year from N/an in Q1 2025, and up 7451.05% on a QoQ basis from 9.12% in Q4 2025.

Standard Biotools (LAB) has 17 years of Net Margin data on file, last reported at 670.07% in Q1 2026.

  • Quarterly Net Margin rose 68324.0% year-over-year to 670.07% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 104.54% (up 19072.0% YoY) and the FY2025 annual result came in at 87.77%, up 6271.0% from the prior year.
  • Net Margin climbed to 670.07% in Q1 2026 per LAB's latest filing, from 9.12% in the prior quarter.
  • Across five years, Net Margin topped out at 670.07% in Q1 2026 and bottomed at 338.46% in Q2 2022.
  • The 5-year median for Net Margin is 81.21% (2025), against an average of 51.46%.
  • The widest annual swing landed in 2022, when Net Margin plunged 28313 bps; it then jumped 68324 bps in 2026.
  • Tracing LAB's Net Margin over 5 years: stood at 7.25% in 2022, then surged by 1112 bps to 73.36% in 2023, then plunged by 249 bps to 109.67% in 2024, then soared by 92 bps to 9.12% in 2025, then surged by 7451 bps to 670.07% in 2026.
  • Per Business Quant, the three latest LAB Net Margin figures stand at 670.07% (Q1 2026), 9.12% (Q4 2025), and 162.05% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.65%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 12.38%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 12.75%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 16.74%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 8.01%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn 670.07%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 670.07%
Dec 31, 2025 -9.12%
Sep 30, 2025 -162.05%
Jun 30, 2025 -81.21%
Mar 31, 2025 -13.17%
Dec 31, 2024 -109.67%
Sep 30, 2024 -99.24%
Jun 30, 2024 -113.12%
Mar 31, 2024 -70.61%
Dec 31, 2023 73.36%
Sep 30, 2023 -82.97%
Jun 30, 2023 -61.59%
Mar 31, 2023 -67.20%
Dec 31, 2022 -7.25%
Sep 30, 2022 -114.79%
Jun 30, 2022 -338.46%
Mar 31, 2022 -287.74%
Sep 30, 2021 -48.57%
Jun 30, 2021 -55.32%
Mar 31, 2021 -57.30%
Dec 31, 2020 -40.41%
Sep 30, 2020 -15.05%
Jun 30, 2020 -49.95%
Mar 31, 2020 -515.48%
Dec 31, 2019 -39.10%
Sep 30, 2019 -48.64%
Jun 30, 2019 -48.78%
Mar 31, 2019 -84.57%
Dec 31, 2018 -45.81%
Sep 30, 2018 -50.93%
Jun 30, 2018 -61.45%
Mar 31, 2018 -52.47%
Dec 31, 2017 -37.53%
Sep 30, 2017 -64.43%
Jun 30, 2017 -70.93%
Mar 31, 2017 -67.29%
Dec 31, 2016 -70.57%
Sep 30, 2016 -89.22%
Jun 30, 2016 -66.09%
Mar 31, 2016 -68.56%
Dec 31, 2015 -41.92%
Sep 30, 2015 -32.36%
Jun 30, 2015 -53.24%
Mar 31, 2015 -59.60%
Dec 31, 2014 -32.68%
Sep 30, 2014 -46.53%
Jun 30, 2014 -45.94%
Mar 31, 2014 -59.92%
Dec 31, 2013 -22.24%
Sep 30, 2013 -23.44%
Jun 30, 2013 -23.15%
Mar 31, 2013 -24.43%
Dec 31, 2012 -23.00%
Sep 30, 2012 -32.48%
Jun 30, 2012 -35.37%
Mar 31, 2012 -61.12%
Dec 31, 2011 -26.60%
Sep 30, 2011 -42.37%
Jun 30, 2011 -67.95%
Mar 31, 2011 -198.21%
Dec 31, 2010 -32.13%
Sep 30, 2010 -812.50%
Jun 30, 2010 -60.06%